Pacific Biosciences of California, Inc. (NASDAQ:PACB) Files An 8-K Results of Operations and Financial Condition
Item 2.02.Results of Operations and Financial Condition.
On April 26, 2017, Pacific Biosciences of California, Inc.
announced its financial results for its first fiscal quarter
ended March 31, 2017. A copy of the press release containing the
announcement is attached as Exhibit 99.1 hereto and is
incorporated herein by reference.
This information, as well as Exhibit 99.1, is intended to be
furnished under Item2.02 of Form 8-K, Results of Operations and
Financial Condition and shall not be deemed filed for purposes of
Section18 of the Securities Exchange Act of 1934, as amended (the
Exchange Act), nor incorporated by reference in any filing under
the Securities Act of 1933, as amended, or the Exchange Act,
except as shall be expressly set forth by specific reference in
such a filing.
|
ITEM9.01. |
FINANCIAL STATEMENTS AND EXHIBITS. |
||||||
|
5 |
|||||||
|
(d) |
Exhibits. |
||||||
|
99.1 |
Press Release dated April 26, 2017 titled Pacific |
||||||
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
Susan |
||
|
Pacific Biosciences of California, Inc. |
||
|
By: |
/s/ Susan K. Barnes |
|
|
Susan K. Barnes
Executive Vice President, Chief Financial Officer |
||
Date: April 26, 2017
EXHIBIT INDEX
|
Exhibit No. |
Description |
|
99.1 |
Press Release dated April 26, 2017 titled Pacific |
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Recent Trading Information
Pacific Biosciences of California, Inc. (NASDAQ:PACB) closed its last trading session at with 655,190 shares trading hands.